lormetazepam has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Foudraine, N; Janssen, PKC; le Noble, JLML; Shudofsky, KN | 1 |
1 other study(ies) available for lormetazepam and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Clearance of Lormetazepam, Midazolam, and Their Conjugated Metabolites by Continuous Venovenous Hemofiltration During Prolonged Sedation in Critically Ill Patients With COVID-19-Associated Acute Respiratory Distress Syndrome.
Topics: Aged; Continuous Renal Replacement Therapy; COVID-19; COVID-19 Drug Treatment; Critical Illness; Deep Sedation; Humans; Hypnotics and Sedatives; Lorazepam; Male; Midazolam; Middle Aged; Respiratory Distress Syndrome | 2022 |